Research on Python Blood Suggests New Weight Loss Treatment

Recent research led by scientists from the University of Colorado Boulder, in collaboration with Baylor University and Stanford University, has unearthed a promising natural compound originating from python blood that may assist in managing hunger effectively. This study, published in the esteemed journal Nature Metabolism, highlights the unique ability of pythons to remain healthy for extended periods without consuming food.

The key to this phenomenon is a molecule known as pTOS, which significantly increases in pythons after they have fed. This compound is thought to play a crucial role in prolonging feelings of fullness, enabling these snakes to go for months without nourishment.

In experiments involving mice, researchers observed notable weight loss without any accompanying muscle loss or substantial adverse side effects. This finding distinguishes the new approach from many existing weight loss medications, which often result in gastrointestinal issues and discomfort for users.

The research team also identified trace amounts of the pTOS compound in humans, suggesting its potential applicability in future therapeutic strategies for weight management.

Following these encouraging results, a biotechnology firm known as Arkana Therapeutics is now focused on developing this compound into safer weight loss medications. These new treatments may not only promote weight loss but could also help mitigate muscle loss as individuals age.

The implications of this research are significant, as it represents a shift towards utilising natural compounds in combating obesity and related health issues.

The findings were detailed in the study, "Python metabolomics uncovers a conserved postprandial metabolite and gut–brain feeding pathway," authored by researchers including Xiao, Wang, and Martin, among others, and published in Nature Metabolism.